1. The effect of iron chelators on iron uptake, ferritin and total protein synthesis was studied in cultured Chang cells. Desferrioxamine depressed ferritin synthesis and completely inhibited iron uptake by ferritin protein. Rhodotorulic acid reduced iron uptake by the cells but had little effect on ferritin synthesis. Diethylenetriamine pentaacetic acid produced complete inhibition of iron uptake and all protein synthesis. 2,3-Dihydroxybenzoic acid (2,3-DHB) had no effect in this system.
Introduction
Little precise information is available regarding the way in which iron enters cells and less is known about its transport within the cell. There is, however, a considerable amount of circumstantial evidence for the existence of a labile pool of iron in reticuloendothelial cells (Lynch, Lipschitz, Bothwell & Charlton, 1974) , small intestinal epithelial cells (Jacobs, 1973) and erythrocyte precursors (Borova, Ponka & Neuwirt, 1973) , and it has been suggested that this pool is in equilibrium both with transferrin iron outside the cell and ferritin iron in the cytoplasm. It is also thought to be available to chelating agents which are able to enter the cell.
Iron stimulates ferritin synthesis in all tissues
which have been studied (Harrison, Hoare, Hoy & Mama, 1974) , and one useful model system which we have used for the study of iron uptake, stimulation of ferritin synthesis and the incorporation of iron into ferritin protein is provided by Chang cell cultures (Chang, 1954) . Nearly 30% of the iron taken up by these cells is bound to membranes and the remainder is found in the supernatant cell sap.
Although most of this is in the form of ferritin, about 35% is unassociated either with ferritin or with haem proteins (Bailey-Wood, White & Jacobs, 1975) . The finding of a large non-ferritin, non-haem pool in Chang cells provides supporting evidence for the existence of a labile pool of iron, and the present paper reports on the use of this system to study the effect of compounds arrmty in 85 iron-chelating agents. 
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Desferrioxamine and diethylenetriamine pentaacetic acid have been widely used in clinical practice for some years. 2,3-Dihydroxybenzoic acid and rhodotorulic acid have recently been introduced as potential iron-chelating agents after screening tests in iron-loaded rats (Graziano, Peterson, Grady, Jones, de Ciutis, Canale, Miller & Cerami, 1975; Grady, Graziano, Akers & Cerami, 1974) . Initial clinical studies with 2,3-DHB(l) have been reported (Graziano et a!., 1975 ). The present investigation shows that all these compounds have a significant effect on intracellular iron metabolism and suggests that the intracellular non-ferritin soluble iron pool is also a chelatable pool.
Materials and methods

Preparation of cells
Chang cells (Flow Laboratories Ltd) were cultured in Minimum Essential Medium containing 10% (v/v) foetal bovine serum. The cells were harvested after 1 week, washed with fresh medium and counted with a haemocytometer.
Chelating agents
The following compounds were used: ethylenediamine tetra-acetic acid (EDTA), desferrioxamine (supplied by Ciba Laboratories) and diethylenetriamine penta-acetic acid (supplied by Sigma Chemicals Ltd). 2,3-DHB and rhodotorulic acid were generously provided by Dr A. Cerami, Rockefeller University.
Preparation of [5gFe]transferrin
[ 59Fe]Transferrin was prepared from iron-deficient human serum. Preliminary estimation of the serum iron concentration and total iron-binding capacity (Young &Hicks, 1965) was followed by the addition of a calculated amount of iron as ferric ammonium citrate labelled with [3gFe]ferric citrate (The Radiochemical Centre, Amersham, Bucks.) to produce 100% saturation (final specific radioactivity 112 pCi/pmol of iron). Passage through an anionexchange column (Cavill, 1971 ) ensured the absence of unbound iron from the final preparation. 
Iron and leucine uptake by Chang cells
Cells (2 x lo6) were incubated at 37°C for 22 h in a mixture of MEM (06 ml) and s9Fe-labelled serum (0.6 ml) with 5 pCi of [3H]leucine (0-005 pmol) under 5% (v/v) COz in air. The iron chelators (100 pl) in MEM at pH 7.4 were added to the incubation mixture to give concentrations between 0 and 6 mmol/l.
After incubation the cells were washed three times with 5 ml of cold MEM and then twice with sodium chloride solution (saline; 154 mmol/l) before sonication in saline (10 ml). A portion (1 ml) of the resulting cell suspension was removed for measurement of total cell uptake of 59Fe and [3H]leucine. The remainder was centrifuged at 20 OOO g for 40 min at 4°C and the supernatant removed, leaving a deposit consisting of disrupted cell membranes. A portion (1 ml) of the supernatant was removed for the measurement of S9Fe and [3Hlleucine content. Purified human spleen ferritin (100 pg) was added to 7 ml of the supernatant and then incubated at 37°C for 1 h after the addition of anti-(human ferritin) serum (50 PI). This results in co-precipitation of the endogenous labelled ferritin. After being left at 4°C overnight the precipitate was washed three times with saline (154 mmol/l) and dissolved in 1 ml of HCI (10 mmol/l). The three 1 ml fractions (cells, cell supernatant and ferritin were counted in an Intertechnique Liquid Scintillation Counter in 10 ml of scintillation cocktail [toluene/Triton X-lOO/PPO/ POPOP (700 ml:350 ml:3.5 g:70 mg)].
In addition to these experiments 2,3-DHB (78 mmol/l) and rhodotorulic acid (78 mmol/l) were incubated with homogenized rat liver (500 mg) in 10 ml of MEM with 10% (vlv) foetal bovine serum for 16 h at 37°C under 5 % (vlv) C o t in air. A control of homogenized liver alone was incubated in the same manner. The suspensions were centrifuged at 100 000 g for 45 min and the supernatants removed and adjusted to pH 7.4. These supernatants were then added to Chang cell suspensions together with sgFe-labelled serum and ["Hlleucine as in the previous experiments. All experiments were carried out in triplicate and the results are expressed as the mean of these values.
Chromatography of cell supernatants
Cells (1 x 10') were incubated with 59Fe-labelled serum for 22 h under standard conditions. They were then washed and sonicated in 5 ml of saline before centrifugation. The membrane-free supernatant was stored in portions at -20°C while awaiting chromatography.
A 1 or 2 ml sample was applied to a Sephadex G-200 column (1.6 cm x 80 cm; bed volume 160 ml) equilibrated with TrkHCl buffer (100 mmolll, pH 7.6) containing NaCl (150 mmol/l). The column was eluted with buffer at 4°C and 2.5 ml fractions were collected at a flow rate of 12 ml/h. The 59Fe radioactivity in the fractions was measured with an LKBWallac Gamma counter. Appreciable amounts of the sgFe were often adsorbed by the gel and it was necessary to wash the column with buffer containing EDTA (50 mmol/l), followed by the normal buffer before applying a further sample.
Iron and leucine loss from Chang cells
Chang cells (2 x lo6 cells/ml) were incubated for 22 h in MEM under standard conditions with 50% (vlv) 59Fe-labelled serum and 5 pCi of [3H]leucinel 2 x lo6 cells. After incubation, the cells were washed five times with fresh MEM and them suspended in the same medium at a concentration of 4 x lo6 cells/ml. A number of tubes were prepared containing 0.6 ml of the cell suspension, 0.6 ml of unlabelled serum (100% saturated with iron) and desferrioxamine at a final concentration of 6 mmolll. The cells were incubated at 37°C under 5% (vlv) C02 in air together with control cultures containing no desferrioxamine. Incubation was stopped by the addition of cold MEM (5 ml) from zero time up to 22 h. The cells were then treated as described above.
Results
Efect of chelators on 59Fe and [3H]leucine uptake by Chaw cells
As the concentration of desfemoxamine in the medium was increased, there was a small decrease in iron uptake by the cells and in the amount of 5gFe present in the cell sap (Fig. la) . There was, however, an almost total inhibition of iron incorporation into ferritin with a corresponding increase in non-ferritin iron. Iron incorporation into ferritin was reduced to 6% of the control value at a desferrioxamine concentration of 1 mmol/l. At a desferrioxamine concentration of 6 mmol/l, there was no significant decrease in total protein synthesis but there was a reduction in ferritin synthesis to 51 % of the control value ( Table 1) . Theaddition of rhodotorulic acid to the incubation medium resulted in a reduction of iron uptake by the cells together with a reduction in the amount of iron finally incorporated into ferritin. There did not appear to be any effect on the amount of iron found in the non-ferritin fraction of the cell sap (Fig. 1 b) . At a rhodotorulic acid concentration of 6 mmol/l iron uptake by the cell was reduced to 64% of the control, and iron incorporation into ferritin was reduced to 42%, but there was no change in either ferritin or total protein synthesis ( Table 3) . When rhodotorulic acid was preincubated with rat liver and the high-speed supernatant added to the Chang cell incubation medium the results were the same as with the untreated chelator (Table 1) .
Incubation with 2,3-DHB produced virtually no change either in iron uptake or ferritin synthesis (Table 1) . However, when this compound was preincubated with a liver homogenate, it produced a decrease in iron incorporation into ferritin and a marked impairment of [3H]leucine incorporation into ferritin and total protein (Table 1 and Fig. 2a) . Inhibition of ferritin synthesis was particularly marked in comparison to total protein synthesis at concentrations below 2 mmol/l, suggesting a specific effect at lower concentrations.
Incubation with DTPA resulted in a marked reduction of the amount of iron in the cells with a progressive change in the distribution of soluble iron between the ferritin and non-ferritin fraction (Fig.  3) . With increasing concentrations a smaller percentage of the soluble iron was found in ferritin until, at a DTPA concentration of 2 mmol/l, nonferritin iron was in excess. At this concentration [3H]leucine incorporation into ferritin was reduced to 63 % but incorporation into total protein only to 87% of control values (Fig. 2b) . At 6 mrnolll there was severe cell damage, with virtually no protein synthesis and little iron uptake or ferritin synthesis (Table 1) .
Gel chromatography
Effect of chelators on intracellular iron. When the membrane-free supernatant from sonicated cells was applied to a Sephadex G-200 column a single radioactive peak was eluted at the void volume and corresponded to the position of a ferritin marker. This peak accounted for about 70% of the total radioactivity applied to the column, the remainder being adsorbed by the gel. The addition of EDTA (5 mmolil) to the supernatant before chromatography resulted in 99% recovery of the supernatant radioactivity, the additional '*Fe appearing as a second peak in the position of a low-molecular-weight complex (Fig. 4) . Addition of rhodotorulic acid and desferrioxamine to the supernatant resulted in the appearance of similar low-molecular-weight fractions (Fig. 4) . Recovery of the supernatant sgFe varied between 91% and 99% in these experiments. When the supernatant was incubated with human iron-deficient serum an additional radioactive peak appeared with the same elution pattern as transferrin (Fig. 4) . Only 84% of the total supernatant "Fe was recovered in this experiment. Dialysis of the supernatant against the incubation mixture for 16 h at 20°C with 6 mm Visking tubing resulted in a loss of 23-26% of the radioactivity.
Effect of incubating cells with chelators. When desferrioxamine (2 mmol/l) was present in the incubation medium subsequent chromatography of the cell supernatant showed no ferritin 5gFe peak but a single low-molecular-weight peak was present corresponding to the position of ferrioxamine. The addition of desferrioxamine or iron-deficient serum to the cell supernatant had no effect on the elution pattern. There was 100% recovery of the 59Fe applied to the column. The proportion of soluble 59Fe found in the form of ferritin was related to the concentration of desferrioxamine in the incubation medium (Fig. 3 , only 7% being found as ferritin with desferrioxamine at 0-1 mmol/l.
Incubation with rhodotorulic acid resulted in a substantial decrease in the amount of s9Fe found in the cells. After exposure to 5 mmol/l of this compound 36% of the supernatant s9Fe was present as ferritin, the remainder being eluted as a low-molecular-weight peak (Fig. 6) . A similar pattern was seen with cell extracts after incubation with DTPA. At a concentration of 2 mmol/l total uptake of iron by the cells was only 20% of that found in control cells. Only 80% of the 59Fe was eluted from the column and of this 67% was present as ferritin and 34 % as a low-molecular-weight complex, presumably with DTPA.
Iron and leucine loss from cells
After incubation for 22 h in the absence of chelating agents, as described above, the cells were incubated again in the same medium containing only cold leucine and iron. No release of s9Fe from the cell, nor any change in 59Fe distribution within the cell, was noted during a 24 h period. There was no loss of [3H]leucine from ferritin but a 22% loss from total protein occurred. When the labelled cells were again incubated in medium containing desferrioxamine (6 mmol/l) there was a rapid release of iron during the first 2 h and a slower rate of release thereafter (Fig. 7) . There was initially a more rapid disappearance from ferritin than from the non-ferritin fraction. When the cells were again incubated with DTPA (2 mmol/l) there was a similar loss of 59Fe from the cells, 28% being lost in 2 h compared with 44% with desferrioxamine. In all these experiments transferrin in the medium was 100% saturated with iron and iron loss from the cell appears to be due to added chelator. When the preincubated cells were placed in non-radioactive medium containing a similar concentration of iron-deficient serum with a transferrin saturation of 7% there was a marked loss of iron from the cells without any addition of a chelating agent. Of the intracellular "Fe 42% was released in 4 h, nearly all of this being accounted for by a fall in the amount of intracellular [59Fel- ferritin. In the subsequent 20 h there was some decrease in the non-ferritin 5gFe.
When the cells were initially incubated with desferrioxamine no labelled ferritin was formed. Subsequent incubation without any chelator in the medium resulted in a substantial loss of 59Fe, this time from the non-ferritin fraction, during the first 2 h followed by a slower release during the subsequent 22 h.
The presence of ascorbic acid (1 mmol/l) in the incubating medium had no effect either on iron incorporation into the cell, iron uptake by ferritin, or on the effect of desferrioxamine on either iron uptake or release.
Discussion
Previous experiments showed that cultured Chang cells take up iron from transferrin at rates which depend on its percentage saturation (Bailey-Wood et al., 1975) . This agrees well with observations on liver slices, reticulocytes and macrophages (Morgan, 1974) . In Chang cells the intracellular distribution of iron is not altered by changes in transferrin saturation and in the present experiments 100% saturation of the carrier protein was used to achieve maximum cell uptake of iron during the incubation.
The results confirm the presence of a large nonferritin, non-haem iron pool. When EDTA, desferrioxamine or rhodotorulic acid were added to the membranefree cell supernatant before gel chromatography this iron was found to be readily chelatable and formed low-molecular-weight complexes which were eluted from Sephadex G-200 in the region of completely excluded molecules (Fig. 4) . When irondeficient serum was added to the supernatant the resulting elution pattern on chromatography suggested binding to transferrin, though in this case about 15% of the iron remained unaccounted for. None of these procedures resulted in any diminution in the amount of ferritin iron in the supernatant and it seems reasonable to use the term 'chelatable iron' for this non-ferritin fraction, though this does not mean that other fractions, such as ferritin, may not also be chelatable under other conditions.
There was no evidence for the existence of transferrin-bound iron within the cell, a suggestion that has been made for reticulocytes (Morgan, 1974) .
When the Chang cells were incubated with desferrioxamine iron uptake was not significantly changed. As the concentration of the chelator increased the proportion of intracellular iron bound as ferrioxamine increased exponentially and the proportion incorporated into ferritin decreased in inverse proportion until at 0.1 mmol/l of chelator accumulation of ferritin iron reached its lowest value (Fig. 5) . Ferritin synthesis is stimulated by iron in all tissues (Harrison et al., 1974) and it has been suggested that this may be consequent upon an increase in the amount of iron in the labile intracellular pool (Lynch et al., 1974) , 1975) . At this concentration of desferrioxamine 90% of the iron in the cell sap is chelated as ferrioxamine and above this concentration synthesis of the protein is inhibited. Chelator concentrations found under clinical conditions are likely to be less than 1 mmol/l and the maximum inhibition of ferritin synthesis by desferrioxamine is well within the clinical concentration range. Experiments in which cells containing labelled ferrioxamine were again incubated in the medium without any additional chelator showed that the labelled complex left the cell rapidly. When cells containing 59Fe distributed normally throughout the cell fractions were incubated with desferrioxamine there appeared to be a greater initial loss of the label from ferritin than from the 'chelatable pool'. However, the available evidence suggests that ferritin iron and the 'chelatable' iron are in equilibrium and removal of 59Fe from the 'chelatable pool' would be expected to result in the observed depletion of ferritin 59Fe. After 24 h ferritin sgFe decreased to 17% and 'chelatable iron' to 21 % of the initial amounts present. Rhodotorulic acid differed somewhat from desferrioxamine in its mode of action. Iron uptake by the cell and incorporation into ferritin was reduced but the synthesis of ferritin protein was unaffected, presumably because adequate amounts of nonchelated iron remained in the cell to stimulate the ferritin synthetic apparatus.
In view of the effect in vivo of 2,3-DHB as an ironchelating agent in hypertransfused rats (Graziano, Grady & Cerami, 1974) it was, perhaps, surprising to find that this compound had no signilicant effect on any aspect of iron metabolism measured in the present study, though it was known that its stability constant for iron is low (k = 3.55) compared with desferrioxamine (k = 32.49). On the assumption that 2,3-DHB may undergo a metabolic change in vivo to convert it into an active chelating agent it was incubated with a rat liver homogenate before being added to the cell culture system. Although iron uptake remained normal after this procedure ferritin synthesis and iron incorporation were both reduced by about SO%, indicating that iron chelation was now occurring. 2,3-DHB is a precursor of the cyclic trimer of dihydroxybenzoylserine (Enterochelin), which is a powerful but relatively unstable iron chelator (Rosenberg & Young, 1974) , and a number of other 2,3-dihydroxybenzoylserine conjugates are known (O'Brien & Gibson, 1970) . It is possible that conversion of the compound into one of these active substances may occur either in vivo or as a result of incubation with liver homogenate.
DTPA behaves as a powerful iron chelator which decreases the total amount of labelled iron in the cell at relatively low concentrations. At concentrations up to 2 mmol/l ferritin "Fe is decreased more rapidly than 'chelatable' 59Fe, in a similar way to that seen with desferrioxamine, and at higher concentrations there is marked inhibition of total protein synthesis as well as ferritin synthesis. The incubation of 59Fe-labelled serum with 6 mmol/l of the chelating agents for 24 h at 37°C did not result in any transfer of the iron to the chelator. It must therefore be assumed that decreased iron incorporation in these experiments is the result of iron chelation and removal from the cell after it has been released by transferrin. This may be in the cytosol or possibly at a site related to the cell membrane.
Iron in the 'chelatable pool' is not only available for incorporation into ferritin but may be utilized for other specific metabolic requirements. A wide variety of metabolic processes such as DNA synthesis (Hoffbrand, Ganeshaguru, Tattersall & Tripp, 1974) , globin chain synthesis (Rabinowitz & Waxman, 1965) , tyrosine hydroxylase (Moore & Dominic, 1971) , proline hydroxylase (Prockop, 1971) activities and others are inhibited by iron-chelating agents and may be assumed to be dependent on iron in an intracellular pool. Both 2,3-DHB, after incubation with liver homogenate, and DTPA inhibited total protein synthesis by the cells and must be considered toxic at the concentrations showing this effect. Neither animal nor human studies have suggested any toxicity from 2,3-DHB (Graziano et al., 1974 (Graziano et al., , 1975 but the possibility should be borne in mind in the investigation of new iron-chelating drugs.
It has been suggested that ascorbic acid potentiates iron chelation, especially with desferrioxamine (Wapnick, Lynch, Charlton, Seftel & Bothwell, 1969;  Model1 & Beck, 1974), but we have found no evidence that this is so nor that ascorbic acid increases the exit of chelated iron from the cell. Although the present data may not be relevant to the iron-overload state, Graziano et ul. (1974) , using iron-loaded rats, have already thrown some doubt on this supposed role for ascorbic acid and its place in chelation therapy must now be reconsidered.
The precise nature of the 'chelatable pool' is not known and its affinity for Sephadex has made its characterization more difficult. It appears to be dialysable and therefore of low molecular weight and its properties conform remarkably well with the endogenous low-molecular-weight ligands postulated by Saltman (1965) to play a key role in intracellular iron metabolism. Further studies with the present system are likely to be of value in determining the nature of this chelatable pool and in the screening of chelating agents, both for their effectiveness and their toxicity.
